Home / Inspections / 596396

FDA Inspection 596396 — Antares Pharma, Inc.

Antares Pharma, Inc. — FEI 2182861

The FDA completed an inspection of Antares Pharma, Inc. on July 14, 2009 in Minnetonka, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 14, 2009
Fiscal Year
2009
Product Type
Devices
Project Area
Compliance: Devices
Location
Minnetonka, MN (United States)

Facility

Other inspections at this facility

  • 1257757 (NAI Thu Jan 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1073695 (VAI Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 963398 (NAI Thu Jan 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 798055 (NAI Thu Sep 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources